Dose: 81 mg
Single Dose: 81 (81)
Frequency: As recommended.
Route: Intra Bladder
Instructions: Diluted in 50ml NS, instilled into empty bladder for 1-2hr as tolerated..

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

Dose: Not applicable in paeds
Single Dose:
Frequency:
Route:
Instructions:

It belongs to CDC Biologicals and Antitumor, Live attenuated strains of M. Bovis pharmacological group.

Tice-BCG is contraindicated in conditions like AIDS,Immunosuppression.

The severe or irreversible adverse effects of Tice-BCG, which give rise to further complications include Anemia, Anemia, Malaise, Arthralgia, Anemia, Renal toxicity, Leukopenia.The symptomatic adverse reactions produced by Tice-BCG are more or less tolerable and if they become severe, they can be treated symptomatically, these include Anorexia, Diarrhea, Abdominal pain, Hematuria, Dysuria, Cramps, Nausea and vomiting, Cystitis, Urinary frequency, UTI, Genital pain.

Tice-BCG is primarily indicated in conditions like Bladder carcinoma, Urethelial cell carcinoma.

No data regarding the interactions of Tice-BCG was found.

If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Vaccination should not be given to pregnant women unless the benefits outweigh the risks. It should be used with caution during lactation. To be most effective, persons who have been vaccinated should stay away from active cases of tuberculosis for 6 to 12 weeks. People with impaired immune systems (due to chemotherapy or radiation treatment) should not receive this vaccine. Inform the doctor if taking any steroid medication (prednisone-type drug) or antibiotic.